Takamichi Baba

Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies

Jean François Timsit, Mical Paul, Ryan K. Shields et al. · Clinical Infectious Diseases · 2022 · 105 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials

Jessica Howard‐Anderson, Toshimitsu Hamasaki, Weixiao Dai et al. · Clinical Infectious Diseases · 2022 · 39 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial

Masaki Kato, Kazuyuki Nakagome, Takamichi Baba et al. · Psychiatry and Clinical Neurosciences · 2023 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Heteroresistance to cefiderocol in carbapenem-resistant <i>Acinetobacter baumannii</i> in the CREDIBLE-CR study was not linked to clinical outcomes: a <i>post hoc</i> analysis

Christopher Longshaw, Anne Santerre Henriksen, Dana C. Dressel et al. · Microbiology Spectrum · 2023 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Peripheral endothelial function can be improved by daily consumption of water containing over 7 ppm of dissolved hydrogen: A randomized controlled trial

Tôru Ishibashi, Kosuke Kawamoto, Kasumi Matsuno et al. · PLoS ONE · 2020 · 17 citations · Full text

Agriculture, Nutrition, Physiology +14